Yangzhi Zhao Selected Research

Yangzhi Zhao Research Topics

2	Disease Progression 01/2023 - 01/2022
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 01/2022
2	Neoplasms (Cancer) 01/2020 - 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2022
1	Triple Negative Breast Neoplasms 12/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Mucositis 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Dysbiosis 01/2020
1	Inflammation (Inflammations) 01/2020
1	Arthritis (Polyarthritis) 07/2019
1	Infections 01/2017

1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 01/2022
1	Brentuximab VedotinIBA 01/2022
1	Circular RNAIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Lenalidomide (CC 5013)FDA Link 01/2021
1	CytokinesIBA 01/2020
1	Acetates (Acetic Acid Esters)FDA Link 01/2020
1	PropionatesIBA 01/2020
1	Butyrates (Butyrate)IBA 01/2020
1	Volatile Fatty AcidsIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2019

4	Therapeutics 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
1	Radiotherapy 01/2023
1	Cranial Irradiation 01/2023
1	Immunotherapy 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Stem Cell Transplantation 01/2022
1	Brachytherapy 01/2020
1	Hematopoietic Stem Cell Transplantation 01/2017